[Current status of the therapy of human African trypanosomiasis].
Dumas
M
M
Breton
J C
JC
Pestre Alexandre
M
M
Girard
P L
PL
Giordano
C
C
D000818:Animals; D001152:Arsenicals / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006019:Glycolysis / Q000187:drug effects; D006801:Humans; D050356:Lipid Metabolism; D008549:Melarsoprol / Q000627:therapeutic use; D011506:Proteins / Q000378:metabolism; D014344:Trypanocidal Agents / Q000627:therapeutic use; D014345:Trypanosoma / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D014353:Trypanosomiasis, African / Q000188:drug therapy / Q000628:therapy*; D014612:Vaccines
D001152:Arsenicals; D011506:Proteins; D014344:Trypanocidal Agents; D014612:Vaccines; D008549:Melarsoprol
Etat actuel de la thérapeutique de la trypanosomiase humaine africaine.